Owner Astellas Pharma Inc.

Inventors Kawaminami, Eiji; Takahashi, Tatsuhisa; Kanayama, Takatoshi; Fukuda, Yuta; Kaizawa, Hiroyuki; Kondoh, Yutaka; Seo, Ryushi; Kuramoto, Kazuyuki; Take, Kazuhiko; Sakamoto, Kazuyuki

Agent Davies Collison Cave

Pub. Number AU-A-2010299114

PCT Pub. Number WO2011/037192

Priority 2009-220316 25.09.09 JP

Filing date 24 September 2010

Wipo publication date 31 March 2011

C07D 207/34 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/341 (2006.01) - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/401 (2006.01) - Proline

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/42 (2006.01) - Oxazoles

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/433 (2006.01) - Thiadiazoles

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/4439 (2006.01)

A61K 31/454 (2006.01)

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/4965 (2006.01) - Non-condensed pyrazines

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/5377 (2006.01)

A61K 31/538 (2006.01)

A61K 31/541 (2006.01) - Non-condensed thiazines containing further heterocyclic rings

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 13/00 (2006.01) Drugs for disorders of the urinary system

A61P 25/00 Drugs for disorders of the nervous system